Literature DB >> 32888314

Neuromedin U: potential roles in immunity and inflammation.

Yuan Ye1,2, Zongan Liang2, Luzheng Xue1.   

Abstract

Since the discovery of neuromedin U (NmU) from porcine spinal cord in 1985, this neuropeptide has been subsequently identified in many other species with multiple physiological and pathophysiological roles detected, ranging from smooth muscle contraction, feeding, energy balance to tumorigenesis. Intriguingly, NmU is also emerging to play pro-inflammatory roles involving immune cell activation and cytokine release in a neuron-dependent or neuron-independent manner. The NmU-mediated inflammatory responses have already been observed in worm infection, sepsis, autoimmune arthritis and allergic animal models. In this review, we focus on the roles of NmU in immunity and inflammation by highlighting the interactions between NmU and immune cells, summarizing the signalling mechanism involved in their reactions and discussing its potential contributions to inflammatory diseases.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  NmUR1; NmUR2; immunity; inflammation; neuromedin U

Mesh:

Substances:

Year:  2020        PMID: 32888314      PMCID: PMC7730025          DOI: 10.1111/imm.13257

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  111 in total

Review 1.  NFAT signaling: choreographing the social lives of cells.

Authors:  Gerald R Crabtree; Eric N Olson
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 2.  The 3 major types of innate and adaptive cell-mediated effector immunity.

Authors:  Francesco Annunziato; Chiara Romagnani; Sergio Romagnani
Journal:  J Allergy Clin Immunol       Date:  2014-12-18       Impact factor: 10.793

3.  Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D(2).

Authors:  Luzheng Xue; Shân L Gyles; Anna Barrow; Roy Pettipher
Journal:  Biochem Pharmacol       Date:  2006-12-01       Impact factor: 5.858

4.  Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway.

Authors:  M Egerton; D R Fitzpatrick; A D Catling; A Kelso
Journal:  Eur J Immunol       Date:  1996-10       Impact factor: 5.532

Review 5.  Neuromedin U: a multifunctional neuropeptide with pleiotropic roles.

Authors:  Vanesa G Martinez; Lorraine O'Driscoll
Journal:  Clin Chem       Date:  2015-01-20       Impact factor: 8.327

Review 6.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

7.  Characterization of neuromedin U like immunoreactivity in rat, porcine, guinea-pig and human tissue extracts using a specific radioimmunoassay.

Authors:  J Domin; M A Ghatei; P Chohan; S R Bloom
Journal:  Biochem Biophys Res Commun       Date:  1986-11-14       Impact factor: 3.575

8.  Role of neuromedin U in accelerating of non-alcoholic steatohepatitis in mice.

Authors:  Hitoshi Teranishi; Masafumi Hayashi; Ryoko Higa; Kenji Mori; Takashi Miyazawa; Jun Hino; Yuichiro Amano; Ryuichi Tozawa; Takanori Ida; Toshikatsu Hanada; Mikiya Miyazato; Reiko Hanada; Kenji Kangawa; Kazuwa Nakao
Journal:  Peptides       Date:  2017-10-07       Impact factor: 3.750

9.  Appetite-modifying actions of pro-neuromedin U-derived peptides.

Authors:  David A Bechtold; Tina R Ivanov; Simon M Luckman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

10.  Epidermal Neuromedin U Attenuates IgE-Mediated Allergic Skin Inflammation.

Authors:  Yoshiko Mizukawa; Takaaki Doi; Yoshimi Yamazaki; Akihiko Kudo; Tetsuo Shiohara
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

View more
  8 in total

Review 1.  Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology.

Authors:  Shogo Sunaga; Junya Tsunoda; Toshiaki Teratani; Yohei Mikami; Takanori Kanai
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

2.  Neuromedin U Suppresses Collagen-Induced Arthritis through ILC2-Th2 Activation.

Authors:  Yuanyuan Zhang; Yi Qin; Zhu Chen
Journal:  J Immunol Res       Date:  2021-03-08       Impact factor: 4.493

3.  Neuronal GPCR NMUR-1 regulates distinct immune responses to different pathogens.

Authors:  Phillip Wibisono; Shawndra Wibisono; Jan Watteyne; Chia-Hui Chen; Durai Sellegounder; Isabel Beets; Yiyong Liu; Jingru Sun
Journal:  Cell Rep       Date:  2022-02-08       Impact factor: 9.423

4.  Moniezia benedeni infection enhances neuromedin U (NMU) expression in sheep (Ovis aries) small intestine.

Authors:  Wan-Ling Yao; Li-Ping Liu; Yan-Qiao Wen; Bao-Shan Wang; Jia-Qi Dong; Wan-Hong He; Xi-Ping Fan; Wen-Hui Wang; Wang-Dong Zhang
Journal:  BMC Vet Res       Date:  2022-04-19       Impact factor: 2.792

5.  Neuromedin U promotes human type 2 immune responses.

Authors:  Yuan Ye; Jian Luo; Ni Zeng; Shan Jiang; Wentao Chen; Ryan D Hoyle; Paul Klenerman; Ian D Pavord; Luzheng Xue
Journal:  Mucosal Immunol       Date:  2022-07-09       Impact factor: 8.701

6.  Bioinformatics analysis of the circRNA-miRNA-mRNA network for atrial fibrillation.

Authors:  Xing Liu; Yiqian Zeng; Zhao Liu; Wenbin Li; Lei Wang; Mingxing Wu
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

7.  NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma.

Authors:  Yan Tang; Chunsheng Hu
Journal:  Dis Markers       Date:  2021-07-12       Impact factor: 3.434

Review 8.  Neuromedins NMU and NMS: An Updated Overview of Their Functions.

Authors:  Ludwik K Malendowicz; Marcin Rucinski
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-01       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.